<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02974842</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN 0276</org_study_id>
    <nct_id>NCT02974842</nct_id>
  </id_info>
  <brief_title>Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance</brief_title>
  <official_title>Cytological Evaluation of Specimens Collected With the MAKO 7 Device in Pre Salpingo-Oophorectomy Subjects for Determination and/or Differentiation of Normal Versus Atypical Versus Malignant Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>nVision Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>nVision Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the ability of the MAKO 7 device to collect various cells
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multi-center observational study to evaluate the ability of the MAKO 7 device to
      collect cells from the fallopian tubes for cytological evaluation for determination and/or
      differentiation of normal versus atypical versus malignant cells.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2, 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance between cytology and pathology results</measure>
    <time_frame>Up to 60 days post-operatively</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>BRCA1 Mutation</condition>
  <condition>BRCA2 Mutation</condition>
  <condition>Atypia Suspicious for Malignancy</condition>
  <arm_group>
    <arm_group_label>Pre-Salpingo-Oophorectomy</arm_group_label>
    <description>Women with pelvic mass suspicious for malignancy or have BRCA1 or BRCA2 mutations that will undergo pre-salpingo-oophorectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MAKO 7</intervention_name>
    <description>Hysteroscopic cell sampling</description>
    <arm_group_label>Pre-Salpingo-Oophorectomy</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cell samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with pelvic mass suspicious for malignancy or have BRCA1 or BRCA2 mutations that put
        them at high risk of developing malignancy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is medically cleared for surgery

          2. Subject is scheduled to undergo a salpingo‚Äêoophorectomy for a pelvic mass suspicious
             for malignancy or for BRCA1 or BRCA2 mutations

          3. Subject must be 18 years of age

          4. Subject must be able to provide informed consent

        Exclusion Criteria:

          1. Contraindication to hysteroscopy

          2. Acute pelvic inflammatory disease

          3. Active or recent lower pelvic infection

          4. Pregnancy

          5. Delivery or termination of a pregnancy in the past 6 weeks

          6. Known tubal obstruction including tubal ligation

          7. Invasive carcinoma of the cervix or endometrium

          8. Intolerance of anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2016</study_first_submitted>
  <study_first_submitted_qc>November 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

